Literature DB >> 15668874

Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease.

Shmuel Shoham1, Cameron Cover, Nancy Donegan, Eric Fulnecky, Princy Kumar.   

Abstract

Meningitis due to Cryptococcus neoformans may be associated with elevated intracranial pressure (ICP), but management of this complication is often overlooked. We retrospectively analyzed 39 consecutive patients with cases of culture-proven, community-acquired meningitis and ascertained adherence to Infectious Diseases Society of America (IDSA) practice guidelines for management of cryptococcal meningitis. Of these 39 patients, 26 (67%) had infection due to C. neoformans. Cerebrospinal fluid opening pressure had been measured for 13 (50%) of these 26 patients, and major deviations from the guidelines with respect to ICP management were observed in the care of 14 (54%). Seven (50%) of these 14 patients developed neuropathies during therapy, compared with 1 of the 5 patients whose care had minor or no deviations from the guidelines (P=.024). Major departures from the IDSA guidelines for management of ICP due to C. neoformans meningitis are common and can be associated with neurological injury during therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668874     DOI: 10.1086/427213

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  Relevance of intracranial hypertension control in the management of Cryptococcus neoformans meningitis related to AIDS.

Authors:  L de Vedia; A Arechavala; M I Calderón; E Maiolo; A Rodríguez; N Lista; E Di Virgilio; J C Cisneros; R Prieto
Journal:  Infection       Date:  2013-12       Impact factor: 3.553

2.  Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIV.

Authors:  Andrej Spec; Margaret A Olsen; Krunal Raval; William G Powderly
Journal:  Clin Infect Dis       Date:  2016-12-07       Impact factor: 9.079

Review 3.  Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Authors:  Peter R Williamson; Joseph N Jarvis; Anil A Panackal; Matthew C Fisher; Síle F Molloy; Angela Loyse; Thomas S Harrison
Journal:  Nat Rev Neurol       Date:  2016-11-25       Impact factor: 42.937

Review 4.  Fungal infections of the CNS: treatment strategies for the immunocompromised patient.

Authors:  Katharine E Black; Lindsey R Baden
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.

Authors:  Ryosuke Osawa; Barbara D Alexander; Olivier Lortholary; Françoise Dromer; Graeme N Forrest; G Marshall Lyon; Jyoti Somani; Krishan L Gupta; Ramon Del Busto; Timothy L Pruett; Costi D Sifri; Ajit P Limaye; George T John; Goran B Klintmalm; Kenneth Pursell; Valentina Stosor; Michele I Morris; Lorraine A Dowdy; Patricia Muñoz; Andre C Kalil; Julia Garcia-Diaz; Susan Orloff; Andrew A House; Sally Houston; Dannah Wray; Shirish Huprikar; Leonard B Johnson; Atul Humar; Raymund R Razonable; Robert A Fisher; Shahid Husain; Marilyn M Wagener; Nina Singh
Journal:  Transplantation       Date:  2010-01-15       Impact factor: 4.939

6.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

Review 7.  Invasive fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham; Kieren A Marr
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

Review 8.  Cryptococcal infections: changing epidemiology and implications for therapy.

Authors:  Ricardo M La Hoz; Peter G Pappas
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

9.  Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.

Authors:  Radha Rajasingham; Melissa A Rolfes; Kate E Birkenkamp; David B Meya; David R Boulware
Journal:  PLoS Med       Date:  2012-09-25       Impact factor: 11.069

10.  Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure.

Authors:  Angela Loyse; Helen Wainwright; Joseph N Jarvis; Tihana Bicanic; Kevin Rebe; Graeme Meintjes; Thomas S Harrison
Journal:  AIDS       Date:  2010-01-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.